Solventum Corporation $SOLV Shares Sold by Creative Planning

Creative Planning reduced its position in shares of Solventum Corporation (NYSE:SOLV) by 5.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 24,970 shares of the company’s stock after selling 1,534 shares during the period. Creative Planning’s holdings in Solventum were worth $1,894,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in SOLV. Sumitomo Mitsui DS Asset Management Company Ltd increased its stake in Solventum by 0.7% during the second quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 19,778 shares of the company’s stock valued at $1,500,000 after purchasing an additional 140 shares during the last quarter. Tradition Wealth Management LLC lifted its position in shares of Solventum by 1.6% in the 1st quarter. Tradition Wealth Management LLC now owns 8,830 shares of the company’s stock worth $671,000 after buying an additional 143 shares during the last quarter. Applied Finance Capital Management LLC boosted its holdings in shares of Solventum by 3.8% in the 2nd quarter. Applied Finance Capital Management LLC now owns 4,428 shares of the company’s stock valued at $336,000 after buying an additional 162 shares during the period. SouthState Corp grew its position in shares of Solventum by 31.9% during the 1st quarter. SouthState Corp now owns 699 shares of the company’s stock valued at $53,000 after buying an additional 169 shares during the last quarter. Finally, HB Wealth Management LLC grew its position in shares of Solventum by 5.6% during the 2nd quarter. HB Wealth Management LLC now owns 3,463 shares of the company’s stock valued at $263,000 after buying an additional 185 shares during the last quarter.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the stock. Jefferies Financial Group started coverage on shares of Solventum in a report on Thursday, September 11th. They issued a “hold” rating and a $80.00 target price on the stock. Piper Sandler raised their price target on Solventum from $94.00 to $98.00 and gave the stock an “overweight” rating in a report on Friday, November 7th. UBS Group restated a “neutral” rating on shares of Solventum in a research report on Friday, November 21st. Wall Street Zen raised Solventum from a “hold” rating to a “buy” rating in a research report on Sunday. Finally, Wells Fargo & Company boosted their price target on shares of Solventum from $79.00 to $82.00 and gave the company an “equal weight” rating in a report on Monday, September 15th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $85.56.

Solventum Stock Down 0.5%

SOLV opened at $85.37 on Thursday. The stock’s 50 day moving average price is $73.34 and its 200 day moving average price is $73.49. The company has a debt-to-equity ratio of 1.03, a current ratio of 1.50 and a quick ratio of 1.14. The stock has a market cap of $14.81 billion, a P/E ratio of 9.84, a P/E/G ratio of 9.05 and a beta of 0.48. Solventum Corporation has a 12 month low of $60.70 and a 12 month high of $86.81.

Solventum (NYSE:SOLV) last released its quarterly earnings results on Thursday, November 6th. The company reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.43 by $0.07. The company had revenue of $2.10 billion during the quarter, compared to analysts’ expectations of $2.05 billion. Solventum had a return on equity of 28.01% and a net margin of 18.13%.The company’s revenue for the quarter was up .7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.64 earnings per share. Solventum has set its FY 2025 guidance at 5.980-6.080 EPS. As a group, research analysts predict that Solventum Corporation will post 6.58 earnings per share for the current year.

Solventum declared that its board has approved a stock buyback plan on Thursday, November 20th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the company to reacquire up to 7.5% of its shares through open market purchases. Shares buyback plans are generally an indication that the company’s management believes its shares are undervalued.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.